| University of California , M.B.A |
Amy joined ATV’s healthcare practice in 2006 where she focuses on investments in the medical device sector in the firm’s Palo Alto, CA office.
Prior to joining ATV, Amy was at Guidant Corporation (later Abbott Vascular) leading the international launch of the Xience drug eluting stent. The launch marked the company’s entrance into the $5 billion worldwide DES market. Amy has launched and managed product in the US, Europe and Asia working closely with clinical, regulatory, manufacturing, R&D, and sales. In addition, Amy spent time in Bristol-Myers Squibb’s international group working on several cardiovascular and neuroscience projects. She began her career as a Management Consultant for APM/CSC Healthcare where she worked on projects with almost 40 hospitals across the US and Canada.
Amy holds an M.B.A from the Walter Haas School of Business at the University of California at Berkeley and a B.A. from Yale University. She is also a Kauffman Fellow.
